Dr. Gerald Diaz @GeraldMD
23.4M 13.8K 7.2K
Board Certified Internal Medicine Hospitalist, GrepMed Editor in Chief 🇵🇭 🇺🇸 - Sign up for an account to like, bookmark and upload images to contribute to our community platform. Follow us on IG: https://www.instagram.com/grepmed/ | Twitter: https://twitter.com/grepmeded/
Contributor Ranks
Latest Searches
9 results
diabetes pharmacology comparison differential algorithm antidiabetic criticalcare decisionaid dermatology diabetic dosing dpp4 erythemas eudka euglycemic hivaids hypocalcemia idsa infections inhibitors
Profiles of Antidiabetic Medications - AACE 2018 #Antidiabetic #Medications #Profiles #SideEffects #Table #DecisionAid #Orals #DM2 #Diabetes
of Antidiabetic Medications ... #Antidiabetic #Medications ... #SideEffects #Table ... DecisionAid #Orals #DM2 ... #Diabetes #Endocrinology
Diabetes Medications Summary Table Insulin Lifestyle modifications Metformin Sulfonylureas GLP-1 receptor agonists - ↓ major adverse CV events TZDs DPP-4 inhibitors SGLT2 inhibitors -
Diabetes Medications ... Summary Table ... #diabetes #medications ... #management #endocrinology ... #dm2
Hypocalcemia - Diagnosis and Management PTH Independent (↑ PTH) • LOW VIT D -
Hypocalcemia - Diagnosis ... and Management ... - Metabolism: Drugs ... Transfusions - Medications ... #Management #endocrinology
DPP4 Inhibitors - Normal and Renal Dosing Increase Incretins (GLP-I & GIP) -> Stimulates Insulin, Inhibits Glucagon
different than other medications ... This drug class ... #Pharmacology #Management ... #Diabetes #DM2 ... #Endocrinology
Euglycemic Diabetic Ketoacidosis (EuDKA) SGLT2 Inhibitors Increasing Indications Significant Adverse Drug Effects Definition of EuDKA • Metabolic acidosis with pH
Inhibitors Increasing Indications ... Significant Adverse Drug ... Ketoacidosis #EuDKA #diagnosis ... #management #endocrinology
Pancreatitis management checklist Evaluation to guide etiology & management - RUQ ultrasound - Calcium
checklist Evaluation ... - Review of medication ... potentially causative drugs ... limit them as able ... #Diagnosis #Management
Rybelsus (oral semaglutide) - First Oral GLP-1 Agonist Dosing: 3 mg daily x 30 days, then 7 mg
to remain stable ... take any other medications ... patients to take meds ... weight loss when compared ... #Pharmacology #Endocrinology
Erythemas Summarized Erythema ab igne • A dermatosis that results from repeated exposure to heat (fires, heating
autoimmune conditions, medications ... idiopathic, and medications ... malignancies, and drugs ... Erythemas #comparison #table ... #differential #diagnosis
IDSA Recommendations for Treating Mycobacterium Tuberculosis Infection and Disease in HIV-AIDS Treating LTBI (to prevent TB disease) Indications:
prevent TB disease) Indications ... and molecular diagnostic ... Please refer to the table ... below for TB drug ... Prevention #Treatment #management
empty